Sellas Life Sciences Group Inc (NASDAQ:SLS)
| 1.71 Delayed Data As of Jun 05 |  0.00 / 0.00%Today’s Change | 1.17 Today|||52-Week Range 5.58 | -27.54% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 355.0K | 142.0K | 0.00 | -- | ||
| Operating Expenses | Gross Income | -355.0K | -142.0K | 0.00 | 0.00 | |
| General Expenses | 33.9M | 31.7M | 15.5M | 21.5M | ||
| Research And Development | 23.6M | 19.9M | 6.1M | 8.8M | ||
| Total Operating Expenses | 34.2M | 31.9M | 15.5M | 21.5M | ||
| Non-Operating Expenses | Operating Income | -34.2M | -31.9M | -15.5M | -21.5M | |
| Extraordinary Credit | 1.7M | 27.3M | 0.00 | 6.1M | ||
| Extraordinary Charge | -5.3M | -2.8M | -7.6M | -12.6M | ||
| Interest Expense On Debt | 760.0K | 3.5M | 462.0K | 266.0K | ||
| Other Expenses | 0.00 | 0.00 | 0.00 | -727.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -38.6M | -10.9M | -23.5M | -29.0M | |
| Income Taxes | -365.0K | -243.0K | -253.0K | -1.4M | ||
| Preferred Dividend | 0.00 | 0.00 | 0.00 | -13.1M | ||
| Discontinued Operations | -20.4M | -12.4M | 0.00 | 0.00 | ||
| Extraordinary Items | -4.5M | 0.00 | 0.00 | 0.00 | ||
| Net Income | -59.4M | -23.5M | -24.4M | -28.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 258.8K | -- | 78.0K | 13.1M | |
| Shares To Calculate EPS Diluted | 258.8K | -- | 78.0K | 13.1M | ||
| Earnings Per Share | EPS | -$246.00 | -- | -$313.20 | -$3.15 | |
| EPS Diluted | -$229.36 | -- | -$313.20 | -$3.15 | ||
